IPP Bureau
ICMR approves Krivida Novus RT-PCR kit
By IPP Bureau - January 19, 2022
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
Menarini Diagnositcs PCR kit identifies Omicron variant
By IPP Bureau - January 18, 2022
It provides Covid-19 detection and Omicron surveillance in less than two hours
Abbisko Therapeutics enters global tie-up with Lilly to develop novel molecules
By IPP Bureau - January 18, 2022
The tie-up combines Abbisko Therapeutics’ proprietary drug discovery platform with Lilly’s disease and discovery expertise
Lupin to acquire supplements portfolio of Anglo-French Drugs & Industries for Rs 325 crore
By IPP Bureau - January 18, 2022
The acquisition would enable addition of established brands with high recall amongst healthcare professionals, especially in the vitamins, minerals and supplements category
Philips integrates cloud-based AI and 3D mapping into Zenition
By IPP Bureau - January 18, 2022
New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
.jpg "TPVI offers a ray of hope for children with Pulmonic Valve disease")
TPVI offers a ray of hope for children with Pulmonic Valve disease
By IPP Bureau - January 18, 2022
Extending nonsurgical treatment options for Failing Pulmonic Valve in patients with congenital heart disease using Transcatheter Pulmonary Valve
Solvay awards €300k science prize to Prof Katalin Kariko for research in mRNA technology
By IPP Bureau - January 18, 2022
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
DCGI approves Phase 3 clinical trial of Stempeucel to treat Covid-19 patients
By IPP Bureau - January 18, 2022
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Cosette Pharma acquires rights to Daiichi Sankyo’s eight branded products
By IPP Bureau - January 18, 2022
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
BiologyWorks k(now) handheld molecular device 99.1 % accurate to RT-PCR test
By IPP Bureau - January 18, 2022
Results from the BiologyWorks k(now) molecular test were 99.1% in overall percent agreement with the results of the RT-PCR lab tests
Anurag Yadav is the new Chief Executive Officer of IHH Healthcare India
By IPP Bureau - January 17, 2022
Prior to IHH, Anurag held senior leadership roles in Fortis Healthcare and Manipal Health Enterprises.
Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson injection
By IPP Bureau - January 17, 2022
The company has 47 ANDA's pending approval with the U.S.FDA
Dr Charles Woler is the new Chairman of Sygnature Discovery
By IPP Bureau - January 17, 2022
Dr Woler joins Sygnature Discovery after the company received significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co, in 2021
Green Valley receives US FDA approval for Phase II clinical trial for Parkinson’s disease
By IPP Bureau - January 17, 2022
The global multi-center phase-II clinical trial will be a 36-week, multi-center, randomized, double-blind, placebo-controlled trial, followed by a 36-week open-label extension period
ICRA expects hospitals to report robust revenue and margin expansion in FY22
By IPP Bureau - January 17, 2022
Occupancy is expected to be in the range of 60-62% while Average Revenue Per Occupied Bed (ARPOB) is expected to expand by least 6% in FY2022
